193 related articles for article (PubMed ID: 25470713)
1. Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.
Zhu HH; Huang XJ
N Engl J Med; 2014 Dec; 371(23):2239-41. PubMed ID: 25470713
[No Abstract] [Full Text] [Related]
2. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
[TBL] [Abstract][Full Text] [Related]
3. Oral arsenic and all-
Zhu HH; Liu YR; Jia JS; Qin YZ; Zhao XS; Lai YY
Blood; 2018 Jun; 131(26):2987-2989. PubMed ID: 29728404
[No Abstract] [Full Text] [Related]
4. Outpatient oral treatment for acute promyelocytic leukemia.
Lo-Coco F; Cicconi L
N Engl J Med; 2015 Feb; 372(9):884-5. PubMed ID: 25714181
[No Abstract] [Full Text] [Related]
5. Outpatient oral treatment for acute promyelocytic leukemia.
Zhu HH; Huang XJ
N Engl J Med; 2015 Feb; 372(9):885. PubMed ID: 25714180
[No Abstract] [Full Text] [Related]
6. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.
Breccia M; Molica M; Efficace F; Minotti C; Latagliata R; Foà R; Lo Coco F
Br J Haematol; 2014 Nov; 167(3):428-30. PubMed ID: 24957334
[No Abstract] [Full Text] [Related]
8. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
[TBL] [Abstract][Full Text] [Related]
10. Perioperative retinoic acid syndrome in a patient with acute promyelocytic leukemia.
Usoltsev NA; Dhamee MS
J Clin Anesth; 2012 Jun; 24(4):315-7. PubMed ID: 22608587
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
Huang H; Qin Y; Xu R; You X; Teng R; Yang L; Xu M; Liu H
Leuk Res; 2012 Jul; 36(7):841-5. PubMed ID: 22534100
[TBL] [Abstract][Full Text] [Related]
12. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
Sasaki M; Sugimoto K; Isobe Y; Oshimi K
Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
[No Abstract] [Full Text] [Related]
13. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ
Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413
[No Abstract] [Full Text] [Related]
15. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia.
Colucciello M
Arch Ophthalmol; 2003 Jul; 121(7):1064-5. PubMed ID: 12860824
[No Abstract] [Full Text] [Related]
16. High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Leuk Res; 2013 Jan; 37(1):37-42. PubMed ID: 23017225
[TBL] [Abstract][Full Text] [Related]
17. Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
Thomas X; Pigneux A; Raffoux E; Huguet F; Caillot D; Fenaux P
Haematologica; 2006 Jul; 91(7):996-7. PubMed ID: 16757416
[TBL] [Abstract][Full Text] [Related]
18. Atypical presentation of retinoic acid syndrome that mimics septic arthritis in a patient with acute promyelocytic leukemia.
Akoz AG; Engin H; Oztoprak N
Acta Oncol; 2007; 46(8):1193-4. PubMed ID: 17851840
[No Abstract] [Full Text] [Related]
19. Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.
Strocchio L; Gurnari C; Santoro N; Putti MC; Micalizzi C; Zecca M; Cuccurullo R; Girardi K; Diverio D; Testi AM; Lo-Coco F; Locatelli F
Br J Haematol; 2019 Apr; 185(2):360-363. PubMed ID: 30028005
[No Abstract] [Full Text] [Related]
20. [A breakthrough for treatment of acute leukemia with a vitamin A acid derivative].
Stolt CM
Lakartidningen; 1992 Apr; 89(18):1565-6. PubMed ID: 1579022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
